The Effect of Emotional Freedom Technique on Depressive Symptom, Anxiety and Psychological Distress of Individuals With New Diagnosis Multiple Sclerosis: A Randomized Controlled Study

CompletedNot a drug-phase studyMS (type not specified)NCT04969562

What it found

No results found

We found no results in the registry or in papers.

This trial finished 5 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • Emotional Freedom Technique

What it measured

Main measures

  • Change from baseline anxiety levels at 6 weeks assessed by anxiety subscale of Hospital Anxiety Depression Scale (HADS)

    Change from Baseline Anxiety at 6 weeks

    Mood and sleep
  • Change from baseline depressive symptoms levels at 6 weeks assessed by depressive symptoms subscale of Hospital Anxiety Depression Scale (HADS)

    Change from Baseline depressive symptoms at 6 weeks

    Mood and sleep
  • Change from baseline psychological distress symptoms levels at 6 weeks assessed by Subjective Units of Distress Scale (SUDS).

    Change from Baseline distress at 6 weeks

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

1. Being over 18 years old 2. Being cooperative and oriented enough to follow the given instructions 3. Having been diagnosed with MS in the last three months 4. Having been on MS treatment for at least a month 5. Getting a score of 3 and above on the SUDS scale

Exclusion criteria

1. Being in the flare of psychiatric illness 2. Using psychiatric medication for less than three months 3. Having an MS attack

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Volunteers over the age of 18 who applied to the Neurology Outpatient Clinic of Dokuz Eylül University Hospital, who were diagnosed with multiple sclerosis in the last three months, one month after the initiation of treatment and accepted the study, will be included in the study after their eligibility to the sampling criteria is evaluated. EDSS will be applied to the individuals by the specialist physician and they will be directed to the MS daycare unit. Since it is a randomized controlled experimental study, the sampling and follow-up measurements will be carried out by a psychologist in the unit where the study is applied, who does not carry out EFT. Scales will be applied in the daily unit and will be randomly divided into two groups at the beginning of the study. The psychologist who chooses the sampling will not know which group the participants will fall into, and the EFT practitioner will not know the anxiety, depression and psychological distress levels of the individuals participating in the study. EFT will be applied to one of the groups, and the other group will continue their routine treatment. Individuals with multiple sclerosis in the experimental group seven days at intervals, six sessions in which one session lasts 30-45 minutes will be included in the EFT application. SUDS will be applied before and after each EFT session. At the same time, resting heart rate and blood pressure will be measured in the EFT group before and after each session. Depression, anxiety and psychological distress levels of individuals with MS will be evaluated with HAD and SUDS at the beginning of the study, at the end of six sessions and in the first month.

Loading reviews and guidelines…

History

    1. Started

      Aug 2020

    2. Main results due

      Oct 2021

    3. Finished

      Oct 2021

    Assembled by software from public sources.